Dendritic cell/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant (HCT) results in long-term sustained T cell activation and clonotypic expansion Meeting Abstract
| Authors: | Karagkouni, D.; Cheloni, G.; Torres, D.; Chung, D.; Shah, N.; Callander, N.; Chodon, T.; Efebera, Y.; Geller, N.; Hematti, P.; Lazarus, H.; Malek, E.; McCarthy, P.; Nooka, A.; Rosenblatt, J.; Rapoport, A.; Soiffer, R.; Bisharat, L.; Stroopinsky, D.; Waller, E.; Pasquini, M.; Vlachos, I.; Avigan, D. |
| Abstract Title: | Dendritic cell/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant (HCT) results in long-term sustained T cell activation and clonotypic expansion |
| Meeting Title: | 20th Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Sep 27-30 |
| Meeting Location: | Athens, Greece |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S43 |
| End Page: | S44 |
| Language: | English |
| ACCESSION: | WOS:001079705400072 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01638-5 |
| Notes: | Meeting Abstract: P-020 -- Source: Wos |
